Membership

RFP, CGN and CGA Opportunities

The Alliance is a community dedicated to connecting healthcare education professionals to promote best practices that improve patient care. To help achieve this, we collect information on research proposals and grants offered through other healthcare-related organizations. If your company is interested in posting a request for grant applications, please contact the Alliance Business Office at acehp@acehp.org

American Academy of Dermatology

The Academy bestows a number of prestigious awards to recognize the contributions of individuals to the specialty as well as offering various grants and scholarships to assist recipients in furthering their areas of study and broadening knowledge in the field of dermatology.

Program for Innovative Continuing Medical Education in Dermatology (PICMED)

The program was established to facilitate dermatologists' continuing education through support and development of innovative continuing medical education programs.

Available grants

  • Multi-year grant: Applicants may request up to $50,000 (direct costs only) for a two (2) year funding period.  2nd year funding will be contingent on 1st year milestones being met. 
  • Single-year grant: Applicants may request up to $10,000 (direct costs only) for a one (1) year project period. 

For more information regarding PICMED, please visit the AAD website.


Bioverativ

Bioverativ, a Sanofi company is committed to supporting innovative, high quality, independent medical education for healthcare professionals (HCPs) that narrows unmet educational needs, maintains clinical excellence, and is designed to change HCP competence and performance, ultimately leading to improved outcomes in the patient communities that Bioverativ serves.

The intent of the Request for Educational Grant Applications (REGA) announcement is to notify experienced and eligible medical education providers that Bioverativ, a Sanofi company is interested in receiving applications for independent medical education activities pertinent to hemophilia or other rare blood disorders and are related to these therapeutic areas:

  • Hemophilia
  • Cold Agglutinin Disease

To access these Request for Grant Applications, please visit the Bioverativ Grants and Giving website.


Bristol-Myers Squibb

Bristol-Myers Squibb accepts funding requests within the following therapeutic areas of interest. As areas of interest and funding consideration may change periodically, please consult this website frequently. Please note that international funding opportunities may differ.

  • Cardiovascular
  • Immunoscience
  • Oncology
  • Virology
  • Genetically Defined / Rare Diseases

View Request for Proposals / for Education


ER/LA Opioid Analgesics REMS Program Companies (RPC)

The Opioid REMS Program Companies (RPC) Continuing Education (CE) Subteam would like to notify you that the 2018 Request for Application (RFA) for REMS-compliant accredited educational grant has been posted here. The 2018 CE Grant Cycle is open to all CE Providers interested in receiving funding for REMS-compliant accredited CE programs under RFA 090618. REMS-compliant educational activities must cover all portions of the revised FDA “Blueprint”, which can be accessed here.

The RPC intends to complete the review process and notify applicants of grant decisions as early as possible in the fourth quarter (October, November, December), 2018.

The deadline for submission of applications for this RFA is 11:59 pm ET, Monday, 9/10/2018. Beginning 6/29/2018, applications must be submitted through the RPC grant management system portal, accessible via this link: grants.er-la-opioidrems.com.


Genentech

Genentech supports grants for independent medical education in an effort to further the advance of medicine and healthcare by improving the knowledge of the medical community.

Genentech is seeking to support educational initiatives in lung cancer, hemophilia and multiple sclerosis that engage clinicians and patients in their care through shared decision making (SDM).

Executive Summaries due May 22, 2018

View Call for Grant Notification


Insmed Incorporated

Insmed has funding to support independent accredited education intended to improve clinician knowledge, competence, and performance in the diagnosis and treatment of patients with Nontuberculous Mycobacterial (NTM) Lung Disease. Please refer to www.insmed.com/grants-giving/ for grant submission requirements. For additional questions about the CGA process please contact Insmed Medical Education at grants@insmed.com. Grant submissions should align to the specifications in the downloadable CGA.

Therapeutic Areas: Pulmonology/Infectious Disease
Nontuberculous Mycobacterial (NTM) Lung Disease
Focus Area: Local and Regional Education Activities

Submission Deadline: Rolling submissions accepted for 2018/2019
Download Call for Grants

Therapeutic Areas: Pulmonology/Infectious Disease
Nontuberculous Mycobacterial (NTM) Lung Disease
Focus Area: Education Activities associated with 2019 ATS and other Medical Society Conferences

Submission Deadline: at least 60 days prior to the requestors need for funding commitment, or based on society deadlines.
Download Call for Grants


Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)

The Centers for Medicare & Medicaid Services (CMS) recognizes the benefits of measure development by external stakeholders with specific knowledge of clinician and patient perspectives and needs, such as clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities. 

On March 2, 2018 CMS published the “Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program” on Grants.gov. The purpose of this Funding Opportunity is to provide technical and funding assistance in the form of cooperative agreements to entities to develop, improve, update, or expand quality measures for use in the Quality Payment Program (QPP). 

For more information and to see the ‘Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program’ search by the title or the Catalog of Federal Domestic Assistance (CFDA) number, 93.986 on Grants.gov.


Pfizer Independent Grants for Learning & Change (IGLC)

The mission of Pfizer Independent Grants for Learning & Change is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. The Joint Commission is an independent, not-for-profit organization that accredits and certifies nearly 21,000 health care organizations and programs in the United States. 

To view open RFPs and complete details, please visit this webpage


Sanofi US Medical Affairs

You are invited to submit a grant proposal to address the educational need outlined in this RFP document. Please review and return your completed proposal via the Sanofi U.S. Grant Website at https://sgrants.envisionpharma.com/vt_sgrants/ by 5pm ET on Friday, August 25, 2018. If a submission is not completed by this date, your proposal will not be accepted.

When entering proposal into the website, please reference the following:

Therapeutic Area: Immunology
Area of Interest: Atopic Dermatitis
RFP Name: RFP-AD-US-Global-1

Please note that an applicant may be ineligible to receive a grant in response to this request for proposal (RFP) if the applicant has performed any services under contract with Sanofi U.S. during the last 12 months in connection with a consultant meeting or an advisory board meeting in the same therapeutic area as this RFP. If the applicant has performed such services, please forward a copy of the contract immediately, prior to responding to the RFP, so that we can determine your eligibility.  If not, please acknowledge this in your application writing.

Please note that you must answer the question, “Are you responding to an RFP” and select “RFP-AD-US-Global-1” from the RFP dropdown panel within the grant portal upon submitting your application for this RFP.

Submission instructions are available on the website. If you have a content question, please contact Sharon Barnett at Sharon.Barnett2@sanofi.com.


Sanofi US Medical Affairs

You are invited to submit a grant proposal to address the educational need outlined in this RFP document. Please review and return your completed proposal via the Sanofi U.S. Grant Website at https://sgrants.envisionpharma.com/vt_sgrants/ by 5pm ET on Thursday, August 16, 2018. If a submission is not completed by this date, your proposal will not be accepted.

When entering proposal into the website, please reference the following:

Therapeutic Area: Immunology
Area of Interest: Atopic Dermatitis
RFP Name: RFP-AD-US-Specialists

Please note that an applicant may be ineligible to receive a grant in response to this request for proposal (RFP) if the applicant has performed any services under contract with Sanofi U.S. during the last 12 months in connection with a consultant meeting or an advisory board meeting in the same therapeutic area as this RFP. If the applicant has performed such services, please forward a copy of the contract immediately, prior to responding to the RFP, so that we can determine your eligibility.  If not, please acknowledge this in your application writing.

Please note that you must select the type of activity that you are proposing, i.e., Live, Enduring or Live and Enduring and answer the question, “Are you responding to an RFP." Please select “RFP-AD-US-Specialists" from the RFP dropdown panel within the grant portal upon submitting your applicant for this RFP.

Submission instructions are available on the website. If you have a content question, please contact Sharon Barnett at Sharon.Barnett2@sanofi.com.


Society for Academic Continuing Medical Education (SACME)

The Research Committee of the Society for Academic Continuing Medical Education (SACME) requests Letters of Intent (LOI) for original, scientific research related to physician and/or health professionals lifelong learning. Opportunities for research funding are one of the benefits of SACME membership. 

Proposals will not be restricted to a particular methodological approach or topic area within CME/CPD/IPE. However, the project must be theory based and methodologically sound. The finished work must be appropriate for publication in a health professions education journal (e.g. Journal of Continuing Education in the Health Professions, Academic Medicine) or equivalent peer reviewed journal, as well as for presentation at a future SACME Annual Meeting (Phil R. Manning Research Award Plenary) or CPD World Congress.

Funding: A grant will be awarded up to a total amount of $50,000 over two years. The next grant award decision will be made by the end of January 2019. The protocol for disbursement of funds is provided in a separate document. 

The submission process closes Tuesday, September 4, 2018Click here for additional information + submission details.


Vertex Pharmaceuticals

Vertex currently has funding to support an accredited, live symposium at the North American Cystic Fibrosis Conference (NACFC) 2018 Annual Meeting being held October 18th – 20th accompanied by an accredited web-based, enduring activity utilizing content from the symposium.

 Please refer to vrtxgrants.com for grant submission requirements. For additional questions about the RFP process, please contact Vertex Grants at vertex_grants@vrtx.com.

Vertex is committed to supporting accredited, independent medical education programs and/or materials for healthcare professionals that aim to improve their skills and knowledge with the goal of improving patient outcomes. Consideration will be given to independent medical education that is high-quality, balanced, scientifically rigorous, free from commercial influence or bias and compliant with the PhRMA Code, ACCME guidelines, and applicable laws. 

Therapeutic Area: Cystic Fibrosis
Areas of Interest: Vertex is interested in supporting an innovative learning program that enhances the understanding of topics such as, but not limited to:

  • Early manifestations of Cystic Fibrosis
  • Strategies to intervene in an effort to ensure the best possible patient outcomes

Submission Deadline: Midnight, August 3rd, 2018
Download RFP